ERBB2 and cancer: The high incidence of ErbB2 abnormal expression in this disease makes the involvement of nucleolin in ErbB2 signaling especially intriguing, and offers new insights on the development and progression of ErbB2-driven breast cancer, as well as on novel targets for cancer therapy.